Global Origin and Transmission of Hepatitis C Virus Nonstructural Protein 3 Q80K Polymorphism

被引:38
作者
McCloskey, Rosemary M. [1 ]
Liang, Richard H. [1 ]
Joy, Jeffrey B. [1 ]
Krajden, Mel [2 ]
Montaner, Julio S. G. [1 ,3 ]
Harrigan, P. Richard [1 ,3 ]
Poon, Art F. Y. [1 ,3 ]
机构
[1] Univ British Columbia, BC Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, BC Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
基金
加拿大健康研究院;
关键词
hepatitis C virus; Q80K; simeprevir; ancestral reconstruction; molecular phylogenetics; virus evolution; phylogeography; PROTEASE INHIBITORS; VIROLOGICAL RESPONSE; MUTATION-RATE; GENOTYPE; HCV; RESISTANCE; SIMEPREVIR; EPIDEMIC; SEQUENCE; TMC435;
D O I
10.1093/infdis/jiu613
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis C virus (HCV) has a naturally occurring polymorphism, Q80K, in the nonstructural protein 3 (NS3) gene encoding the viral protease, which has been associated with reduced susceptibility to the direct-acting antiviral inhibitor simeprevir. Q80K is observed predominantly in HCV genotype 1a and seldom in other HCV genotypes; moreover, it has a markedly high prevalence in the United States. Here, we reconstruct the evolutionary history of this polymorphism to investigate why it is so highly localized in prevalence and whether it is stably transmitted between hosts. We found that the majority (96%) of HCV infections carrying Q80K were descended from a single lineage in which a Q80K substitution occurred around the 1940s in the United States, which implies that this polymorphism is likely highly transmissible. Furthermore, we identified 2 other substitutions in NS3 that may interact with Q80K and contribute to its stability. Our results imply that the current distribution and prevalence of Q80K are unlikely to change significantly in the short term.
引用
收藏
页码:1288 / 1295
页数:8
相关论文
共 42 条
[1]   GENOMIC CHARACTERIZATION AND MUTATION-RATE OF HEPATITIS-C VIRUS ISOLATED FROM A PATIENT WHO CONTRACTED HEPATITIS DURING AN EPIDEMIC OF NON-A, NON-B HEPATITIS IN JAPAN [J].
ABE, K ;
INCHAUSPE, G ;
FUJISAWA, K .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2725-2729
[2]  
[Anonymous], STAT METHODS MOL EVO
[3]   Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors [J].
Bae, Andrew ;
Sun, Siu-Chi ;
Qi, Xiaoping ;
Chen, Xiaowu ;
Ku, Karin ;
Worth, Angela ;
Wong, Kelly A. ;
Harris, Jeanette ;
Miller, Michael D. ;
Mo, Hongmei .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) :5288-5297
[4]   HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors [J].
Cento, Valeria ;
Mirabelli, Carmen ;
Salpini, Romina ;
Dimonte, Salvatore ;
Artese, Anna ;
Costa, Giosue ;
Mercurio, Fabio ;
Svicher, Valentina ;
Parrotta, Lucia ;
Bertoli, Ada ;
Ciotti, Marco ;
Di Paolo, Daniele ;
Sarrecchia, Cesare ;
Andreoni, Massimo ;
Alcaro, Stefano ;
Angelico, Mario ;
Perno, Carlo Federico ;
Ceccherini-Silberstein, Francesca .
PLOS ONE, 2012, 7 (07)
[5]   Biopython']python: freely available Python']Python tools for computational molecular biology and bioinformatics [J].
Cock, Peter J. A. ;
Antao, Tiago ;
Chang, Jeffrey T. ;
Chapman, Brad A. ;
Cox, Cymon J. ;
Dalke, Andrew ;
Friedberg, Iddo ;
Hamelryck, Thomas ;
Kauff, Frank ;
Wilczynski, Bartek ;
de Hoon, Michiel J. L. .
BIOINFORMATICS, 2009, 25 (11) :1422-1423
[6]  
De Luca A, 2013, ANTIVIR THER, V18, pA47
[7]  
Delano W.L., 2002, PYMOL MOL GRAPHICS S, V30, P442
[8]   Inference of viral evolutionary rates from molecular sequences [J].
Drummond, A ;
Pybus, OG ;
Rambaut, A .
ADVANCES IN PARASITOLOGY, VOL 54: THE EVOLUTION OF PARASITISM-A PHYLOGENETIC PERSPECTIVE, 2003, 54 :331-358
[9]   BEAST: Bayesian evolutionary analysis by sampling trees [J].
Drummond, Alexei J. ;
Rambaut, Andrew .
BMC EVOLUTIONARY BIOLOGY, 2007, 7 (1)
[10]   Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial [J].
Forns, Xavier ;
Lawitz, Eric ;
Zeuzem, Stefan ;
Gane, Ed ;
Bronowicki, Jean Pierre ;
Andreone, Pietro ;
Horban, Andrzej ;
Brown, Ashley ;
Peeters, Monika ;
Lenz, Oliver ;
Ouwerkerk-Mahadevan, Sivi ;
Scott, Jane ;
De La Rosa, Guy ;
Kalmeijer, Ronald ;
Sinha, Rekha ;
Beumont-Mauviel, Maria .
GASTROENTEROLOGY, 2014, 146 (07) :1669-+